Madrigal Pharmaceuticals (NASDAQ:MDGL) Hits New 1-Year High on Better-Than-Expected Earnings
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $377.46 and last traded at $355.88, with a volume of 1187957 shares traded. The stock had previously closed at $309.49. The biopharmaceutical company reported ($2.71) […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The stock traded as high as $377.46 and last traded at $355.88, with a volume of 1187957 shares traded. The stock had previously closed at $309.49. The biopharmaceutical company reported ($2.71) […]
